Results 11 to 20 of about 400,917 (195)
Autoimmune Hemolytic Anemia in the Pediatric Setting
Journal of Clinical Medicine, 2021 Autoimmune hemolytic anemia (AIHA) is a rare disease in children, presenting with variable severity. Most commonly, warm-reactive IgG antibodies bind erythrocytes at 37 °C and induce opsonization and phagocytosis mainly by the splenic macrophages ...
A. Voulgaridou, T. Kalfa
semanticscholar +1 more source
PLoS ONE, 2022 BackgroundImmune hemolytic anemia commonly affects human immune deficiency infected individuals. Among anemic HIV patients in Africa, the burden of IHA due to autoantibody was ranged from 2.34 to 3.06 due to drug was 43.4%.
Samuel Sahile Kebede +5 more
doaj +2 more sources
The Autoimmune Hemolytic Anemia following Septic Shock with Escherichia Coli; a Case Report
Archives of Academic Emergency Medicine, 2023 Sepsis is a severe, life-threatening illness caused when the immune system responds inappropriately to infections, causing organ deterioration and negatively affecting the systems inside the body, one of which is the coagulation system. Most hematologic
Duong Le Xuan +5 more
doaj +1 more source
Cefazolin-induced hemolytic anemia: a case report and systematic review of literature
European Journal of Medical Research, 2021 Background Cefazolin is a first-generation cephalosporin commonly used for skin and soft tissue infections, abdominal and orthopedic surgery prophylaxis, and methicillin-sensitive staph aureus.
Elizabeth Mause +2 more
doaj +1 more source
Definitions, 2020 Copyright 2013, Turner White Communications, Inc., Strafford Avenue, Suite 220, Wayne, PA 19087-3391, www.turner-white.com. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by
Bruce M. White +5 more
semanticscholar +1 more source
Hemolytic Anemia Complicating COVID-19 Infection
Journal of Hematology, 2021 Coronavirus disease 2019 (COVID-19) has been associated with a spectrum of reported hematological complications ranging from immune cytopenias to thromboembolic manifestations of coagulopathy.
Abeer N. Abouyabis, Grace Thompson Bell
semanticscholar +1 more source
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Frontiers in Immunology, 2020 Autoimmune hemolytic anemias mediated by cold agglutinins can be divided into cold agglutinin disease (CAD), which is a well-defined clinicopathologic entity and a clonal lymphoproliferative disorder, and secondary cold agglutinin syndrome (CAS), in ...
S. Berentsen
semanticscholar +1 more source
The Changing Landscape of Autoimmune Hemolytic Anemia
Frontiers in Immunology, 2020 Autoimmune hemolytic anemia (AIHA) is a greatly heterogeneous disease due to autoantibodies directed against erythrocytes, with or without complement activation.
W. Barcellini, B. Fattizzo
semanticscholar +1 more source
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
Journal of Clinical Medicine, 2020 Autoimmune hemolytic anemia (AIHA) is a highly heterogeneous disease due to increased destruction of autologous erythrocytes by autoantibodies with or without complement involvement. Other pathogenic mechanisms include hyper-activation of cellular immune
W. Barcellini +3 more
semanticscholar +1 more source
Autoimmune hemolytic anemia: current knowledge and perspectives
Immunity & Ageing, 2020 Autoimmune hemolytic anemia (AIHA) is an acquired, heterogeneous group of diseases which includes warm AIHA, cold agglutinin disease (CAD), mixed AIHA, paroxysmal cold hemoglobinuria and atypical AIHA.
S. Michalak +5 more
semanticscholar +1 more source